Abilita Therapeutics Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
13

- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
Abilita Therapeutics General Information
Description
Developer of oncological drugs designed to target membrane proteins. The company leverages technology-directed evolution to identify target variants (EMPs) that can overcome the challenges, yet maintain the relevant protein structure, enabling clinicians to have access to tool receptors for antibody discovery and technical service through the generation of enabled membrane proteins.
Contact Information
Website
abilitatx.comCorporate Office
- 5785 Oberlin Drive
- Suite 100
- San Diego, CA 92121
- United States
Corporate Office
- 5785 Oberlin Drive
- Suite 100
- San Diego, CA 92121
- United States
Abilita Therapeutics Timeline
Abilita Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
5. Seed Round | 21-Feb-2023 | Completed | Pre-Clinical Trials | |||
4. Grant | 15-Sep-2021 | Completed | Product Development | |||
3. Grant | 20-Sep-2016 | Completed | Product Development | |||
2. Accelerator/Incubator | 01-Jan-2015 | Completed | Product Development | |||
1. Angel (individual) | 01-Jan-2015 | Completed | Product Development |
Abilita Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed-3 | ||||||||
Seed-2 | ||||||||
Seed-1 | 177,788 | $0.000010 | 8% | $1.49 | $1.49 | 1x | $1.49 | 2.29% |
Seed | 2,114,462 | $0.000010 | 8% | $3.55 | $3.55 | 1x | $3.55 | 19.76% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Abilita Therapeutics Patents
Abilita Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250092146-A1 | Anti-ccr8 antibodies, conjugates, and uses thereof | Pending | 28-Apr-2023 | ||
US-10845367-B2 | Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents | Active | 04-May-2016 | ||
US-20190137496-A1 | Methods and platform for preparing multispanning membrane proteins | Active | 04-May-2016 | ||
EP-3452516-A1 | Methods and platform for preparing multispanning membrane proteins | Pending | 04-May-2016 | ||
EP-3452516-A4 | Methods and platform for preparing multispanning membrane proteins | Pending | 04-May-2016 | G01N33/577 |
Abilita Therapeutics Signals
Abilita Therapeutics Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Two Bear Capital | Venture Capital | Minority | ||
U.S. Department of Health and Human Services | Government | |||
Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
CONNECT(San Diego) | Accelerator/Incubator |
Abilita Therapeutics FAQs
-
When was Abilita Therapeutics founded?
Abilita Therapeutics was founded in 2014.
-
Where is Abilita Therapeutics headquartered?
Abilita Therapeutics is headquartered in San Diego, CA.
-
What is the size of Abilita Therapeutics?
Abilita Therapeutics has 13 total employees.
-
What industry is Abilita Therapeutics in?
Abilita Therapeutics’s primary industry is Drug Discovery.
-
Is Abilita Therapeutics a private or public company?
Abilita Therapeutics is a Private company.
-
What is Abilita Therapeutics’s current revenue?
The current revenue for Abilita Therapeutics is
. -
How much funding has Abilita Therapeutics raised over time?
Abilita Therapeutics has raised $7.5M.
-
Who are Abilita Therapeutics’s investors?
Two Bear Capital, U.S. Department of Health and Human Services, Johnson & Johnson Innovation - JLABS, and CONNECT(San Diego) have invested in Abilita Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »